<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02476474</url>
  </required_header>
  <id_info>
    <org_study_id>133508</org_study_id>
    <nct_id>NCT02476474</nct_id>
  </id_info>
  <brief_title>GERD Following Laparoscopic Sleeve Gastrectomy</brief_title>
  <official_title>Antral Length and GERD Following Sleeve Gastrectomy for Morbid</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laparoscopic Sleeve Gastrectomy (LSG) creates a vertical gastrectomy which results in a
      narrow and tubular shape of stomach. The line of resection starts at 3-6 cm. from pylorus
      (antrum) toward to the angle of His. The gastric antrum plays a major role in gastric
      emptying, particularly for solids. Hence, depending upon the starting point of gastric sleeve
      resection in each center, this can result in difference of the remaining gastric antrum which
      may affect gastric emptying time after this procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laparoscopic Sleeve Gastrectomy (LSG), a purely restrictive procedure, has become recently
      one of the most popular bariatric surgical procedures in this decade because its surgical
      technique is simple but outcomes in regards to weight loss and co-morbidities improvement are
      excellent comparable to other procedures. Nevertheless, this procedure carries one potential
      drawback namely &quot;gastroesophageal reflux disease (GERD). The impact on GERD following LSG are
      inconsistent . Additionally, the recent literature can be divided into two categories: those
      that support an increase in GERD prevalence after LSG and those that demonstrate a decrease
      in GERD prevalence after LSG. Postoperatively, one of the proposed mechanisms for either
      increased or decreased GERD prevalence is gastric emptying time. Delayed gastric emptying
      time can contribute to increase intra-gastric volume and pressure resulting in an increase in
      prevalence of GERD after surgery. On the other hand, accelerated gastric emptying time can
      cause decrease in GERD prevalence because of decrease in stomach volume and interorgan
      pressure after operation. In addition, LSG creates a vertical gastrectomy which results in a
      narrow and tubular shape of stomach. The line of resection starts at 3-6 cm. from pylorus
      (antrum) toward to the angle of His. The gastric antrum plays a major role in gastric
      emptying, particularly for solids. Hence, depending upon the starting point of gastric sleeve
      resection in each center, this can result in difference of the remaining gastric antrum which
      may affect gastric emptying time after this procedure. The investigators hypothesize that a
      larger amount of gastric antrum will result in accelerated gastric emptying time which leads
      to less GERD prevalence. On the contrary, the less the remaining gastric antrum would result
      in delayed gastric emptying which contribute to more GERD prevalence. The investigators plan
      on identifying the prevalence of GERD in the patients who undergo LSG comparing those who
      have the sleeve beginning either 3 cm. or 6 cm. from pylorus. We will utilize 24 hour
      esophageal pH monitoring, esophageal manometry, upper gastrointestinal scintigraphy and
      esophagogastroduodenoscopy at preoperatively, 3 and 6 month postoperatively. Ultimately, this
      study will help further clarify the most proper starting resected point of LSG (3 versus 6
      cm. from pylorus) which results in the least GERD prevalence after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time of gastric emptying</measure>
    <time_frame>6 months post surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with GERD</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>3 cm start of resection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The line of resection for the Laparoscopic Sleeve gastrectomy will start at 3 cm from pylorus (antrum).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6 cm start of resection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The line of resection for the Laparoscopic Sleeve gastrectomy will start at 6 cm from pylorus (antrum).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>3 cm start of resection</intervention_name>
    <description>Investigators will start the resection of the LSG 3 centimeters from the antrum of the stomach.</description>
    <arm_group_label>3 cm start of resection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>6 cm start of resection</intervention_name>
    <description>Investigators will start the resection of the LSG 6 centimeters from the antrum of the stomach.</description>
    <arm_group_label>6 cm start of resection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any subject who has already been already cleared for and scheduled to undergo
             laparoscopic sleeve gastrectomy for the treatment of morbid obesity(Utilizing NIH1991
             guideline for bariatric surgery)

        Exclusion Criteria:

          1. Patients not meeting entry criteria to undergo bariatric surgery procedures.

          2. Refusal to give informed consent.

          3. Age &lt;18 or &gt;70.

          4. Prior small intestinal or gastric resective surgery

          5. Existing coagulopathy (INR&gt;2.0, platelet count&lt;100,000)

          6. Severe reflux esophagitis.( Los Angeles Classification for erosive esophagitis grade
             C,D)

          7. Hiatal hernia &gt; 2 cm(according to esophageal manometry or EGD)

          8. Acquired or Congenital Immunodeficiencies

          9. White blood cell count below normal range.

         10. Azotemia - serum creatinine &gt; 2.0 mg/dl
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John P Cello, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <reference>
    <citation>Melissas J, Daskalakis M, Koukouraki S, Askoxylakis I, Metaxari M, Dimitriadis E, Stathaki M, Papadakis JA. Sleeve gastrectomy-a &quot;food limiting&quot; operation. Obes Surg. 2008 Oct;18(10):1251-6. doi: 10.1007/s11695-008-9634-4. Epub 2008 Jul 29.</citation>
    <PMID>18663545</PMID>
  </reference>
  <reference>
    <citation>Laffin M, Chau J, Gill RS, Birch DW, Karmali S. Sleeve gastrectomy and gastroesophageal reflux disease. J Obes. 2013;2013:741097. doi: 10.1155/2013/741097. Epub 2013 Jul 15. Review.</citation>
    <PMID>23956846</PMID>
  </reference>
  <reference>
    <citation>Chiu S, Birch DW, Shi X, Sharma AM, Karmali S. Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surg Obes Relat Dis. 2011 Jul-Aug;7(4):510-5. doi: 10.1016/j.soard.2010.09.011. Epub 2010 Sep 21. Review.</citation>
    <PMID>21130052</PMID>
  </reference>
  <reference>
    <citation>Braghetto I, Davanzo C, Korn O, Csendes A, Valladares H, Herrera E, Gonzalez P, Papapietro K. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg. 2009 Nov;19(11):1515-21. doi: 10.1007/s11695-009-9954-z. Epub 2009 Aug 28.</citation>
    <PMID>19714384</PMID>
  </reference>
  <reference>
    <citation>Weiner RA, Weiner S, Pomhoff I, Jacobi C, Makarewicz W, Weigand G. Laparoscopic sleeve gastrectomy--influence of sleeve size and resected gastric volume. Obes Surg. 2007 Oct;17(10):1297-305.</citation>
    <PMID>18098398</PMID>
  </reference>
  <reference>
    <citation>Bernstine H, Tzioni-Yehoshua R, Groshar D, Beglaibter N, Shikora S, Rosenthal RJ, Rubin M. Gastric emptying is not affected by sleeve gastrectomy--scintigraphic evaluation of gastric emptying after sleeve gastrectomy without removal of the gastric antrum. Obes Surg. 2009 Mar;19(3):293-8. doi: 10.1007/s11695-008-9791-5. Epub 2008 Dec 17.</citation>
    <PMID>19089519</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2015</study_first_submitted>
  <study_first_submitted_qc>June 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2015</study_first_posted>
  <last_update_submitted>November 16, 2017</last_update_submitted>
  <last_update_submitted_qc>November 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>John P. Cello, M.D.</investigator_full_name>
    <investigator_title>Professor of Medicine and Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

